(PRESOLICITATION NOTICE) INTENT TO SOLE SOURCE - BIORAD ANTIBODIES

NOTICE OF INTENT TO AWARD A SOLE SOURCE ACTION to BIORAD Laboratories, for the acquisition of: BIORAD Antibodies

This procurement action is being conducted under the authority of FAR 12.201-1, Simplified procedures, in accordance with Federal Acquisition Regulation (FAR) Procedures for Evaluation and Solicitation for Commercial Items, in conjunction with the policies and procedures for solicitation, evaluation, and award as prescribed in FAR 12.102 Restricting competition.

This Notice of Intent is not a request for Proposals or Quotations. No solicitation document exists, and no telephone or email inquiries will be accepted. No contract award will be made based on proposals, or quotations received in response to this notice. Interested persons may identify their interest and capability to respond to the requirement and should furnish detailed data concerning their capabilities to provide services sought including pricing data and technical data sufficient to determine that a comparable source to the Government is available. The Government may consider all “Expression of Interest” documentation received no later than 1:00AM ET, 1-AUG-2026. A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will normally be considered for the sole purpose of determining whether to conduct a competitive procurement. Responses to this notice must be emailed to AHR0@cdc.gov. Submitters are responsible for ensuring their email reaches the designated contracting officer on-time.